Rating History for Corcept Therapeutics (cort) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for cort
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/30/2026 David Amsellem Maintain Overweight
(N/A)		 165.00
(88.00)		  
 		   Details